Davis's Drug Guide
tofersen
General
Genetic Implications:
Pronunciation:
toe-fer-sen
Trade Name(s)
- Qalsody
Ther. Class.
none assigned
Pharm. Class.
antisense oligonucleotides
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Tofersen." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580101/all/tofersen.
Vallerand AHA, Sanoski CAC. Tofersen. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580101/all/tofersen. Accessed July 14, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Tofersen. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580101/all/tofersen
Vallerand AHA, Sanoski CAC. Tofersen [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 14]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580101/all/tofersen.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tofersen
ID - 3580101
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580101/all/tofersen
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
